In the complex, dynamic world of healthcare, commercial teams are challenged to perform multiple feats: launch new products, gain formulary status, increase margins, expand market share, and outwit competitors — usually against impossibly tight deadlines.
Now, a commercial organization with more projects than people to manage them can speed results and shorten their list by outsourcing a project to a team of graduate students from the USC Healthcare Decision Analysis & Biopharmaceutical Marketing programs.
The USC Enterprise Team Projects team consists of 5-7 graduate students who contribute approximately 1,200 hours to the effort over four months.
Projects can be structured around problems or opportunities including new product commercialization, value and access, pricing and reimbursement, competitive intelligence, product marketing, brand strategy, pipeline and business development, and other key business areas.
“The Healthcare Decision Analysis program has helped me stand out as a candidate for every internship and job opportunity I have pursued since starting the program. Between my didactic courses, the competitive intelligence Enterprise Team Project at Deallus and the market access Enterprise Team Project at Kite Pharma, I have had the opportunity to partake in countless invaluable experiences.”
PharmD ’23, MS Healthcare Decision Analysis ‘23
Research Analyst: Formulary Decisions and Customer Engagement at Xcenda
“Partnering with a USC Enterprise Team was hugely valuable for our business. During what is typically the busiest time of year for us, we were able to deliver and take on more client work as a result of this collaboration. The Enterprise Team was a reliable resource, staffed by bright passionate students, all of whom were quick learners and made an immediate impact on their assigned projects. We will certainly consider repeating this partnership in the future.”
Senior Principal, Deallus Consulting
Read about Enterprise Team Projects program in Results Magazine
Past Projects with Company Sponsors
Evaluation of market access and reimbursement in emerging markets for company’s oncology product portfolio.
Analysis of technology assessment and approval process of large-capital medical device purchases at hospitals.